Clinical trial
Usefulness of Sodium MRI in the Presurgical Assessment of Drug-resistant Partial Epilepsy
NCT02304029 is registered in ClinicalTrials.gov with Assistance Publique Hopitaux De Marseille as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Usefulness of Sodium MRI in the Presurgical Assessment of Drug-resistant Partial Epilepsy
- Lead sponsor
- Assistance Publique Hopitaux De Marseille
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 6, 2015
- Completion date
- November 15, 2019
- Enrollment
- 78 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
epileptic seizures